Matthew Pratt Whalen - 09 Dec 2024 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRA	Stock Options (right to buy)	Award	$0	+25,000		$0.000000	25,000	09 Dec 2024	Common Stock	25,000	$1.19	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.
F2	The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.
F3	25,000 stock options were issued to the Reporting Person on the Grant Date, pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.